Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
Circulation Research|August 1, 1976
Influence of 5- and 6-hydroxydopamine on adrenergic transmission and nerve terminal morphology in the canine pulmonary vascular bedP J Kadowitz, D S Knight, R G Hibbs, et al.
The American Journal of Physiology|May 12, 1998
Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of ratsB Gumusel, Q Hao, A L Hyman, et al.
Molecular Pharmacology|May 1, 1983
Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulationB T Mellion, L J Ignarro, C B Myers, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1978
Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic stateA L Hyman, A A Mathe, C A Leslie, et al.
Prostaglandins, Leukotrienes, and Medicine|May 1, 1985
The effects of amrinone on human platelet aggregation: evidence that amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasmaH L Lippton, P M Horwitz, D B McNamara, et al.
Gene Therapy|December 1, 1995
The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiencyM L Batshaw, M Yudkoff, B A McLaughlin, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|September 25, 1999
Frequency of convergence insufficiency among fifth and sixth graders. The Convergence Insufficiency and Reading Study (CIRS) groupM W Rouse, E Borsting, L Hyman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1995
Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study GroupM C Leske, S Y Wu, L Hyman, et al.
Canadian Journal of Physiology and Pharmacology|August 11, 2005
Potential application for mesenchymal stem cells in the treatment of cardiovascular diseasesBruce A Bunnell, Weiwen Deng, Christine M Robinson, et al.
Pageof 27